# DESCRIPTION

## FIELD OF THE INVENTION

- relate to antibodies with increased half-life

## BACKGROUND OF THE INVENTION

- introduce ferrets as laboratory model
- describe limitations of ferret model
- identify need for novel IgG variants

## SUMMARY OF THE INVENTION

- introduce modified ferret IgG Fc region
- describe increased half-life in ferrets
- provide advantages of increased half-life
- introduce isolated antibody with modified Fc region
- describe substitution at amino acid residue 252
- introduce S252Y or S252M substitutions
- describe increased half-life of modified antibody
- introduce isolated immunoglobulin construct
- describe antibody fragment and modified Fc region
- introduce immunoglobulin fusion protein
- describe bioactive molecule and modified Fc region
- introduce YTE modification
- describe chimeric, ferret, ferretized, or veneered antibody
- introduce human or humanized Fab and modified Fc region
- describe antibody fragment and modified Fc region
- introduce immunoglobulin fusion protein with bioactive molecule
- describe antibody or immunoglobulin construct with moiety
- introduce antibody that specifically binds to RSV F glycoprotein

## DETAILED DESCRIPTION OF THE INVENTION

### General

- define "and/or"
- define "single" and "plurality"
- describe application of examples
- describe variations and modifications
- describe functionally-equivalent products
- describe production methods
- describe references for production methods
- define "comprise"
- describe unmodified antibodies

### DEFINITIONS

- define "corresponding" unmodified antibody
- define "epitope"
- define "antibody"
- describe immunoglobulin or antibody molecule
- describe constant domains
- describe Fc region
- describe CH2 and CH3 domains
- describe hinge region
- describe Fab
- describe scFv
- describe isolated biomolecule
- describe substantially purified biomolecule
- define "immunoglobulin fusion protein"
- describe in vivo half-life
- describe increased half-life
- define "recombinant"
- describe specifically binds
- describe cross-reactivity
- describe KD
- describe affinity
- describe immunoglobulin construct
- describe constant region
- describe constant fragment
- describe FcRn
- describe beta2 microglobulin
- describe numbering of residues

### Amino Acid Substitutions

- describe methods of substituting amino acids
- describe site-directed mutagenesis
- describe PCR-mediated mutagenesis
- describe use of thermostable ligase
- describe use of mutagenic agents
- describe screening mutants
- describe exemplary amino acid substitutions
- describe numbering system

### Antibodies of the Invention

- describe antibodies according to the invention
- describe characteristics of antibodies

### Ferret Antibody Derivatives

- introduce ferret antibody derivatives
- describe conservative amino acid substitutions
- define conservative substitution
- introduce mutations in framework regions
- introduce mutations in CDR regions
- describe silent or neutral missense mutations
- describe non-neutral missense mutations
- design and test mutant molecules
- express and determine functional activity
- describe covalent attachment of molecules
- list examples of chemical modifications
- describe chemical synthesis of peptides
- introduce non-classical amino acids
- describe immunoconjugates

### Immunoglobulin Constructs of the Invention

- define immunoglobulin construct
- describe Fc regions and fusions
- list examples of antibody fragments

### Antibody Preparation

- introduce antibody preparation methods
- describe hybridoma technology
- define monoclonal antibody
- describe production and screening of hybridomas
- generate antibody fragments
- describe phage display methods
- express and isolate antibody coding regions
- describe recombinant production of antibodies

### Recombinant Production of Antibodies and Immunoglobulin Constructs

- introduce recombinant production of antibodies
- isolate and sequence DNA encoding antibodies
- place DNA into expression vectors
- transfect host cells with expression vectors
- produce monoclonal antibodies in host cells
- review recombinant expression in bacteria
- describe molecular cloning techniques
- construct recombinant nucleic acids
- produce recombinant immunoglobulins
- isolate and synthesize DNA encoding antibodies
- insert DNA into replicable vector
- describe vector components
- introduce signal sequence component
- describe prokaryotic signal sequences
- describe yeast signal sequences
- describe mammalian signal sequences
- introduce promoter component
- describe prokaryotic promoters
- describe eukaryotic promoters
- introduce enhancer element component
- describe enhancer sequences
- introduce transcription termination component
- describe transcription termination sequences
- select and transform host cells
- describe suitable host cells
- culture host cells

### Chimeric Antibodies

- define chimeric antibodies
- introduce recombinant means
- describe variable light and heavy chain regions
- specify human variable regions and ferret constant regions
- outline production of chimeric antibodies
- cite references for production methods
- introduce ferretized and ferret antibodies
- define ferret antibodies
- describe ferretized antibodies
- outline methods for ferretizing non-ferret antibodies
- cite references for ferretizing methods
- introduce CDR-grafting
- introduce veneering or resurfacing
- introduce chain shuffling
- describe ferret veneered antibodies
- introduce antibody binding
- outline immunoassays for specific binding
- introduce immunoglobulin fusion proteins
- describe fusion proteins
- outline methods for producing fusion proteins
- cite references for fusion protein production
- introduce polynucleotides
- describe polynucleotides encoding modified antibodies
- outline assays for half-life of antibodies
- introduce use of modified antibodies or immunoglobulin constructs

## EXAMPLES

### Example 1

- introduce pharmacokinetics study
- test human IgG antibody in ferrets
- analyze results

### Example 2

- clone ferret IgG constant region sequences
- analyze cloned sequences

### Example 3

- prepare chimeric ferret/human antibodies
- introduce half-life extending substitutions
- express and purify chimeric mAbs
- analyze purified mAbs

### Example 4

- clone and express soluble ferret FcRn
- analyze expressed FcRn

### Example 5

- test chimeric mAb binding to ferret FcRn
- analyze binding results
- compare binding affinities

### Example 6

- evaluate pharmacokinetics of chimeric mAb variants
- inject ferrets with mAb variants
- collect and analyze blood samples
- determine half-lives of mAb variants
- compare half-lives of variants
- test for anti-drug antibodies
- analyze ADA detection results

